These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6518868)

  • 1. [Harringtonine in the treatment of polycythemia vera--analysis of 12 cases].
    Lu LH
    Zhonghua Nei Ke Za Zhi; 1984 Jul; 23(7):413-5, 462. PubMed ID: 6518868
    [No Abstract]   [Full Text] [Related]  

  • 2. Harringtonine in treatment of polycythemia vera.
    Lu LH; Lin SP; Liang YY; Song TY; Li LY
    Chin Med J (Engl); 1983 Jul; 96(7):533-5. PubMed ID: 6418454
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical analysis of the therapeutic effect of semisynthetic harringtonine in treating 55 cases of nonlymphocytic leukemia (author's transl)].
    Zhang ZY
    Zhonghua Nei Ke Za Zhi; 1981 Nov; 20(11):667-9. PubMed ID: 7341094
    [No Abstract]   [Full Text] [Related]  

  • 4. Curative effect of harringtonine semisynthetic harringtonine and HOAP on nonlymphocytic leukemias. Analysis of 304 cases.
    Zhang ZY; Hou CH; Zhu YF; You XY; Li JL; Fu Z
    Chin Med J (Engl); 1987 Jul; 100(7):565-8. PubMed ID: 3123163
    [No Abstract]   [Full Text] [Related]  

  • 5. Harringtonine in acute leukemias. Clinical analysis of 31 cases.
    Chin Med J (Engl); 1977 Sep; 3(5):319-24. PubMed ID: 411635
    [No Abstract]   [Full Text] [Related]  

  • 6. Small-dose Harringtonine induces complete remission in patients with acute promyelocytic leukemia.
    Ye JS; Wang XH; Feng GH; Liang GR; Liu ZP
    Leukemia; 1988 Jul; 2(7):427-9. PubMed ID: 3164799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A preliminary therapeutic analysis of 82 cases of chronic granulocytic leukemia treated with harringtonine].
    Zhang ZY; Hou CH; Zhu YF
    Zhonghua Nei Ke Za Zhi; 1986 Mar; 25(3):156-7, 190. PubMed ID: 3461929
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intrathecal injection of harringtonine and homoharringtonine in treating central nervous system leukemia--clinical analysis of 26 cases (author's transl)].
    Hou CH; Zhang ZY
    Zhonghua Yi Xue Za Zhi; 1981 Sep; 61(9):530-2. PubMed ID: 6804061
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on the antineoplastic action and toxicity of partially synthetic harringtonine].
    Ji XJ; Zhang FR; Dong XL
    Yao Xue Xue Bao; 1983 Apr; 18(4):299-302. PubMed ID: 6624475
    [No Abstract]   [Full Text] [Related]  

  • 10. Cephalotaxine esters in the treatment of acute leukemia. A preliminary clinical assessment.
    Chin Med J (Engl); 1976 Jul; 2(4):263-72. PubMed ID: 825360
    [No Abstract]   [Full Text] [Related]  

  • 11. Long survival in an elderly patient with acute myeloid leukaemia after treatment with harringtonine.
    Sullivan J; Leyden M
    Med J Aust; 1985 Jun; 142(13):693-4. PubMed ID: 3859742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homoharringtonine as a new antileukemic agent.
    Ohnuma T; Holland JF
    J Clin Oncol; 1985 May; 3(5):604-6. PubMed ID: 3889228
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative in vitro antitumor activity of homoharringtonine and harringtonine against clonogenic human tumor cells.
    Jiang TL; Liu RH; Salmon SE
    Invest New Drugs; 1983; 1(1):21-5. PubMed ID: 6678854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From efficacy to safety: a Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera.
    Fruchtman SM; Mack K; Kaplan ME; Peterson P; Berk PD; Wasserman LR
    Semin Hematol; 1997 Jan; 34(1):17-23. PubMed ID: 9025158
    [No Abstract]   [Full Text] [Related]  

  • 15. Leukemic cell differentiation in vivo and in vitro: arrest of proliferation parallels the differentiation induced by the antileukemic drug Harringtonine.
    Boyd AW; Sullivan JR
    Blood; 1984 Feb; 63(2):384-92. PubMed ID: 6692041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pipobroman in the treatment of some cases of polycythemia vera].
    Bignotti G; Visca U; Confalonieri C
    Haematologica; 1971; 56(3):157-62. PubMed ID: 5003588
    [No Abstract]   [Full Text] [Related]  

  • 17. Intermittent Iv homoharringtonine for the treatment of refractory epithelial carcinoma of the ovary: a phase II trial.
    Kavanagh JJ; Gershenson DM; Copeland LJ; Wharton JT; Rutledge FN; Krakoff IH
    Cancer Treat Rep; 1984 Dec; 68(12):1503-4. PubMed ID: 6542450
    [No Abstract]   [Full Text] [Related]  

  • 18. [Myleran treatment in polycythemia vera].
    Yde H
    Nord Med; 1971 Aug; 85(32):968. PubMed ID: 5568439
    [No Abstract]   [Full Text] [Related]  

  • 19. [The treatment of polycythemia vera with busulfan].
    Kratochvil J; Mrkos D
    Vnitr Lek; 1966 Jul; 12(7):673-81. PubMed ID: 5967585
    [No Abstract]   [Full Text] [Related]  

  • 20. 6-Thioguanine treatment for polycythemia vera and essential thrombocythemia.
    Delfini C; Nicolini G; Durazzi SM; Bartolucci M; Lucarelli G
    Haematologica; 1987; 72(3):273-5. PubMed ID: 3114098
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.